
Quality of life and 6-minute walk test also improve with this treatment combination.

Maggie is a lead editor for The American Journal of Managed Care® (AJMC®), AJMC.com, and Evidence-Based Oncology, for which she produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and she has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.

Quality of life and 6-minute walk test also improve with this treatment combination.

Under the ACA, patients with HIV in Medicaid expansion states have greater access to care.

Tumor inflammatory response is significantly associated with poor prognosis in patients with multiple myeloma.

Researchers aim to eliminate leukemia stem cells safely.

Greater rates of adherence and persistence seen among patients on a single-tablet regimen.

Updated Carthadex trial results show improved responses at the 58-month mark and build on findings from other studies.

For their study, the authors wanted to expand on previous research results that suggest outcomes are improved among patients with multiple myeloma treated at high-volume facilities.

CDC recommends that young men who have sex with men have an HIV test every 6 months.

The rate of decrease in deaths from heart disease (HD) slowed between 2011 and 2014 versus 2000 and 2011, while the population above 65 years jumped 22.9% and there was a concurrent 38% rise in deaths from HD among this patient population.

A recently published commentary examined issues surrounding biosimilars in the treatment of multiple sclerosis from an international point of view, noting the tremendous opportunity for cost savings while wondering if patient concerns are being adequately considered.